Aug 13, 2020
UNION therapeutics A/S enters option agreement to acquire worldwide exclusive license for COVID-19 technologies developed by TFF Pharmaceuticals, Inc.
Aug 13, 2020
VistaGen Therapeutics Reports Fiscal 2021 First Quarter Financial Results and Highlights CNS Pipeline and Business Progress
Aug 13, 2020
Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA
Aug 11, 2020
Eisai Announces Topline Results from Study 211 Supporting 24 mg as the Appropriate Starting Dose for LENVIMA® (lenvatinib) in Patients with Differentiated Thyroid Cancer
Aug 11, 2020
American Society of Ketamine Physicians, Psychotherapists and Practitioners Announces Standards of Practice in the Therapeutic Use of Subanesthetic Ketamine
Jun 10, 2020
Gastroparesis Market Analysis for the 7MM - Epidemiology and Forecasts to 2028
Jun 08, 2020
Neurelis Announces Rapid and Broad Payer Coverage of the Company's Flagship Product, VALTOCO® (Diazepam Nasal Spray)
Jun 06, 2020
Chlorobenzene Market 2020-2024 | Increased Demand for Chlorobenzene from the Chemical Industry to Boost Market Growth | Technavio
Jun 04, 2020
Athlete's Foot - Market Insights, Epidemiology and Forecast to 2030
Jun 03, 2020
The American Society of Ketamine Physicians (ASKP) Announces Name Change
Jun 02, 2020
Association of American Physicians & Surgeons (AAPS) Sues the FDA to End Its Arbitrary Restrictions on Hydroxychloroquine
Jun 02, 2020
WAKIX® (pitolisant) Data From Harmony Biosciences Included on American Academy of Neurology Science Highlights Virtual Platform
May 29, 2020
Lilly's CYRAMZA® (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
May 27, 2020
VistaGen and Nuformix Announce Agreement to Develop Novel Patentable Cocrystalline Forms of AV-101 for Treatment of Multiple CNS Conditions
May 18, 2020
Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company
May 13, 2020
Hydroxychloroquine Market Size Worth Around US$ 6 Bn by 2027
May 05, 2020
FDA approves new treatment for a type of heart failure
May 04, 2020
Coronavirus Victims Die While Government Hoards Medication, Observes the Association of American Physicians & Surgeons
May 04, 2020
Neurelis Announces That Intravail® Licensee, ARS Pharmaceuticals' Intranasal Epinephrine Product, Demonstrates Bioequivalent Exposure To Epinephrine Injectors
Apr 28, 2020
Blueprint Medicines Announces Top-line Results from Phase 3 VOYAGER Trial of Avapritinib versus Regorafenib in Patients with Advanced Gastrointestinal Stromal Tumor